| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
ER-Negative PR-Negative HER2-Negative Breast Cancer
[description not available] | 0 | 2.55 | 2 | 0 |
Leucocythaemia
[description not available] | 0 | 2.21 | 1 | 0 |
Kahler Disease
[description not available] | 0 | 3.92 | 2 | 1 |
Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) | 0 | 2.21 | 1 | 0 |
Multiple Myeloma
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. | 0 | 3.92 | 2 | 1 |
Triple Negative Breast Neoplasms
Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN. | 0 | 2.55 | 2 | 0 |
Germinoblastoma
[description not available] | 0 | 3.17 | 1 | 0 |
B-Cell Chronic Lymphocytic Leukemia
[description not available] | 0 | 5.75 | 2 | 1 |
Lymphoma
A general term for various neoplastic diseases of the lymphoid tissue. | 0 | 3.17 | 1 | 0 |
Leukemia, Lymphocytic, Chronic, B-Cell
A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease. | 0 | 5.75 | 2 | 1 |
Ewing Sarcoma
[description not available] | 0 | 2.31 | 1 | 0 |
Sarcoma, Ewing
A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females. | 0 | 2.31 | 1 | 0 |
Colorectal Cancer
[description not available] | 0 | 2.21 | 1 | 0 |
Colorectal Neoplasms
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. | 0 | 2.21 | 1 | 0 |
Metastase
[description not available] | 0 | 2.1 | 1 | 0 |
Benign Neoplasms
[description not available] | 0 | 5.06 | 3 | 1 |
Angiogenesis, Pathologic
[description not available] | 0 | 2.47 | 2 | 0 |
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. | 0 | 2.1 | 1 | 0 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 1 | 7.06 | 3 | 1 |
Adenocarcinoma Of Kidney
[description not available] | 0 | 2.11 | 1 | 0 |
Cancer of Kidney
[description not available] | 0 | 2.11 | 1 | 0 |
Carcinoma, Renal Cell
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. | 0 | 2.11 | 1 | 0 |
Kidney Neoplasms
Tumors or cancers of the KIDNEY. | 0 | 2.11 | 1 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.13 | 1 | 0 |
Hepatocellular Carcinoma
[description not available] | 0 | 2.13 | 1 | 0 |
Cancer of Liver
[description not available] | 0 | 2.13 | 1 | 0 |
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 1 | 4.13 | 1 | 0 |
Liver Neoplasms
Tumors or cancer of the LIVER. | 0 | 2.13 | 1 | 0 |
Breast Cancer
[description not available] | 0 | 2.05 | 1 | 0 |
Breast Neoplasms
Tumors or cancer of the human BREAST. | 0 | 2.05 | 1 | 0 |
Neuroblastoma
A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) | 1 | 4.06 | 1 | 0 |
Cholera Infantum
[description not available] | 0 | 4.37 | 1 | 1 |
Blood Diseases
[description not available] | 0 | 4.37 | 1 | 1 |
Hypokalemia
Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) | 0 | 4.37 | 1 | 1 |
Diffuse Large B-Cell Lymphoma
[description not available] | 0 | 4.37 | 1 | 1 |
Hematologic Diseases
Disorders of the blood and blood forming tissues. | 0 | 4.37 | 1 | 1 |
Lymphoma, Large B-Cell, Diffuse
Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. | 0 | 4.37 | 1 | 1 |